Company / Working Capital per Share
Gain Therapeutics, Inc. Working Capital per Share History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.47
FY2024
5-year range
$0.47 / $9.93
FY2021-FY2024
Trend
-56.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has declined for 3 consecutive years, from $9.93 in FY2021 to $0.47 in FY2024.
Based on SEC 10-K filings.
0.47 in FY2024 with a 3-year CAGR of -63.7%.
Declined from $1.43 to $0.47 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -63.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Gain Therapeutics, Inc.'s working capital per share has declined for 3 consecutive years.
- In FY2024, working capital per share decreased 56.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -16.87 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.47 | -56.0% |
| FY2023 | $1.08 | -24.4% |
| FY2022 | $1.43 | -85.6% |
| FY2021 | $9.93 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026